AnalystsGena Wang
Gena Wang's Stock Forecasts

Analyst Ranking
Bottom 7%
#4448 out of 4753 analysts
Average Return
-2.37%
Win Rate
36%49 out of 135
Risk vs Reward
Poor
Good

Gena Wang's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Beam Therapeutics IncBEAM
+315.20%$23.02$95.58
2020-03-02 -
2021-03-01
Strong Buy
Moderna IncMRNA
+260.41%$59.10$213.00
2020-06-08 -
2021-06-08
Strong Buy
Biocryst Pharmaceuticals IncBCRX
+170.38%$3.95$10.68
2020-05-05 -
2021-05-05
Strong Buy
Abeona Therapeutics IncABEO
+156.56%$152.50$391.25
2017-01-06 -
2018-01-05
Strong Buy
Avexis IncAVXS
+127.64%$93.30$212.39
2017-09-07 -
2018-04-12
Strong Buy

Gena Wang's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Kodiak Sciences IncKOD
8Strong Sell$4.00-46.16%Maintains
18 days ago
Bluebird Bio IncBLUE
9Strong Buy$2.00+379.62%Maintains
18 days ago
Sangamo Therapeutics IncSGMO
3Strong Buy$9.00+281.36%Maintains
19 days ago
Ptc Therapeutics IncPTCT
13Hold$45.00-13.58%Maintains
19 days ago
Moderna IncMRNA
6Strong Buy$111.00+150.79%Maintains
25 days ago
Intellia Therapeutics IncNTLA
6Strong Buy$55.00+249.65%Maintains
25 days ago
Crispr Therapeutics AgCRSP
13Hold$55.00-0.27%Maintains
a month ago
Editas Medicine IncEDIT
8Hold$5.00+128.31%Maintains
a month ago
Cellectis SaCLLS
2Strong Buy$5.00+147.52%Maintains
a month ago
Biocryst Pharmaceuticals IncBCRX
9Hold$8.00+8.40%Maintains
a month ago
Vir Biotechnology IncVIR
4Strong Buy$26.00+219.02%Maintains
a month ago
Alnylam Pharmaceuticals IncALNY
6Strong Buy$329.00+30.03%Maintains
a month ago
Biomarin Pharmaceutical IncBMRN
5Strong Buy$86.00+32.23%Maintains
2 months ago
Avidity Biosciences IncRNA
1Strong Buy$63.00+52.54%Initiates Coverage On
3 months ago
Solid Biosciences IncSLDB
6Strong Buy$15.00+159.07%Maintains
4 months ago
Sarepta Therapeutics IncSRPT
7Strong Buy$203.00+58.66%Maintains
4 months ago
Beam Therapeutics IncBEAM
8Hold$31.00+9.56%Maintains
4 months ago
Regenxbio IncRGNX
6Strong Buy$50.00+400.00%Maintains
4 months ago
Ultragenyx Pharmaceutical IncRARE
6Strong Buy$81.00+70.17%Maintains
4 months ago
Vertex Pharmaceuticals IncVRTX
13Hold$509.00+9.29%Downgrades
4 months ago
Ionis Pharmaceuticals IncIONS
6Hold$51.00+41.27%Maintains
4 months ago
4d Molecular Therapeutics IncFDMT
1Strong Buy$45.00+492.89%Initiates Coverage On
8 months ago
Legend Biotech CorpLEGN
6Strong Buy$94.00+117.04%Maintains
10 months ago
Mirati Therapeutics IncMRTX
6Strong Buy$71.00N/AMaintains
a year ago
Seagen IncSGEN
3Hold$228.00N/AMaintains
2 years ago
Zymeworks IncZYME
1Hold$9.00N/AMaintains
2 years ago
Arcturus Therapeutics Holdings IncARCT
5Hold$25.00N/AUpgrades
2 years ago
Orchard Therapeutics PLCORTX
2Strong Buy$40.00N/AMaintains
3 years ago
Meiragtx Holdings PLCMGTX
1Strong Buy$18.00N/AMaintains
3 years ago
Tectonic Therapeutic IncTECX
3Strong Buy$48.00N/AMaintains
3 years ago
Decibel Therapeutics IncDBTX
2Strong Buy$7.00N/AMaintains
3 years ago
Sigilon Therapeutics IncSGTX
1Strong Buy$91.00N/AMaintains
3 years ago
Logicbio Therapeutics IncLOGC2
1Strong Buy$8.00N/AMaintains
3 years ago
Axonics IncAXNX
1Strong Buy$79.00N/AMaintains
3 years ago
Aceragen IncACGN
1Hold$2.00N/ADowngrades
4 years ago
Eidos Therapeutics IncEIDX
1Strong Sell$45.00N/ADowngrades
5 years ago
Tesaro IncTSRO
1Hold$75.00N/ADowngrades
6 years ago
Puma Biotechnology IncPBYI
5Strong Sell$29.00N/ADowngrades
6 years ago
Spark Therapeutics IncONCE
4Strong Buy$77.00N/AMaintains
6 years ago
Avexis IncAVXS
3HoldN/AN/ADowngrades
7 years ago
Juno Therapeutics IncJUNO
2HoldN/AN/ADowngrades
7 years ago
Cascadian Therapeutics IncCASC
1Strong Sell$4.00N/AInitiates Coverage On
7 years ago
Abeona Therapeutics IncABEO
1Strong Buy$275.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.